-
Exploratory Assessment of the Societal Impact of Changing Informal Care Hours in the Netherlands
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Immune Checkpoint Inhibitors Chemotherapy (ICI+CT) vs. ICI Monotherapy (ICI) in Untreated Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Use of Multiple Sleep Medications Is Highly Prevalent
Sep 9, 2025, 16:22 PM -
The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria
Sep 9, 2025, 16:22 PM -
US PIE and AMCP Dossiers: Payer Preferences Best Practice and a Comparison With Global Evidence Dossiers
Sep 9, 2025, 16:22 PM -
Evolving Assumptions on Treatment Durability in Cost-Effectiveness Models of Cell and Gene Therapies: Insights From French HTA Submissions
Sep 9, 2025, 16:22 PM -
Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Cefiderocol for the Treatment of Confirmed MBL-Producing Pathogens in Italy
Sep 9, 2025, 16:22 PM -
Constructing a Dynamic Budget Impact Model: An AI Pretraining Approach for a New Parkinson's Disease Drug
Sep 9, 2025, 16:22 PM -
Understanding the Consequences of International Reference Pricing on Cancer Immunotherapy in Europe: A 10-Year Price Corridor Analysis
Sep 9, 2025, 16:22 PM -
Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS
Sep 9, 2025, 16:22 PM -
The Interim Acceptance and Ultraorphan Pathways in Scotland: An Update
Sep 9, 2025, 16:22 PM -
Adherence to Anti-VEGF Treatment of Patients With Age-Related Macular Degeneration of Exudative Type (nAMD) and Diabetic Macular Edema (DME) in Greece: Evidence From an Expert Panel
Sep 9, 2025, 16:22 PM -
Healthcare Burden Among Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer
Sep 9, 2025, 16:22 PM -
Identifying CKD As a Key Driver of CVD Deaths
Sep 9, 2025, 16:22 PM -
From French Early Access to Regular Reimbursement: How Do Prices Shift Post-HTA?
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Early Scientific Advice Mechanisms: EU JSC vs. National HTA Bodies (HAS, G-BA, NICE)
Sep 9, 2025, 16:22 PM
